T-10430 |
T-10430 : Agonist of LTB4R2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| LTB4R2 |
|
Agonist
300-500 nM
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
The GPCR screen (314 receptors, Ca2+ Aequorin assay)
shows no activity at 1 µM except for LTB4R2.
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Off-target test on BLT1 with T-10430 tested as agonist and off-target test on AT1 tested as antagoni ...
Potency Cellular
In Vitro
LTB4R2
Mode of Action: Agonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.4c01617
In Vivo Validations
Mouse
Dose: 10 mg/Kg
Route of delivery:
Subcutaneous
Plasma half life:
62 min
Cmax:
9120 ng/mL
Tmax:
15 min
Area Under the Curve::
245000 ng*min/mL
DOI Reference: 10.1021/acs.jmedchem.4c01617
Dose: 3 mg/kg
Route of delivery:
Intravenous
Plasma half life:
19 min
Cmax:
3290 ng/mg
Area Under the Curve::
61100 ng*min/mL
Bioavailability:
51%
DOI Reference: 10.1021/acs.jmedchem.4c01617
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
154 min
Cmax:
1990 ng/mL
Tmax:
15 min
Area Under the Curve::
104000 ng*min/mL
DOI Reference: 10.1021/acs.jmedchem.4c01617
Negative Control Compounds
canSAR7402268
Notes: Inactive at BLT2 (IP-One) up to 100 μM, EC50 (BLT2 cAMP) = 560 nM, 1000-fold higher EC50 in cAMP assay.
Chemical Information
| Molecular Formula | C17H22N6O |
| SMILEs | CCCCC(=O)N1CC2(C1)CN(c1ccccc1-c1nnn[nH]1)C2 |
| InChI | InChI=1S/C17H22N6O/c1-2-3-8-15(24)23-11-17(12-23)9-22(10-17)14-7-5-4-6-13(14)16-18-20-21-19-16/h4-7H,2-3,8-12H2,1H3,(H,18,19,20,21) |
| Molecular weight | 326.19 Da |
| AlogP | 1.7055 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 46 |